Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, Krönke G, Simon D, Schönau V, Hueber A, Kleinert S, Baraliakos X, Fleck M, Rubbert-Roth A, Behrens F, Kofler D, Feuchtenberger M, Zaenker M, Voll R, Glaser C, Feist E, Burmester G, Karberg K, Strunk J, Canete JD, Naredo E, Filkova M, Senolt L, Schett G (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: WILEY
City/Town: HOBOKEN
Pages Range: 939-941
Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY
APA:
Rech, J., Hueber, A., Ostergaard, M., Tascilar, K., Hagen, M., Mendez, L.V.,... Schett, G. (2021). Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients. In ARTHRITIS & RHEUMATOLOGY (pp. 939-941). HOBOKEN: WILEY.
MLA:
Rech, Jürgen, et al. "Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2021. 939-941.
BibTeX: Download